Literature DB >> 12359050

Temperature-sensitive ovarian carcinoma cell line (OvBH-1).

Julia K Bar1, Antonina Harlozinska, Sabine Kartarius, Mathias Montenarh, Ewa Wyrodek, Jan M Rodriguez Parkitna, Marian Kochman, Andrzej Ozyhar.   

Abstract

OvBH-1 cells from a patient with ovarian clear cell carcinoma were established and their biochemical status was analyzed. Cells grown at 37 degrees C exhibited normal cell cycle distribution, whereas the cells shifted to 31 degrees C were arrested in the G(2) / M phase of the cell cycle. Immunochemical analysis using anti-p53 antibodies (DO-1, PAb240, PAb421, and PAb1620) revealed that only the DO-1 antibody reacted with p53 with a high and similar percentage at both temperatures. PAb240 reacted with a low percentage of cells at 37 degrees C and no reaction was observed at 31 degrees C. PAb421 antibody stained a significantly lower percentage of cells at 37 degrees C than at 31 degrees C. Cells were not stained with PAb1620 antibody and were negative for antibodies against p21(WAF1) and MDM2 proteins independently of the temperature. Sequencing of all coding exons of the p53 gene demonstrated only a neutral genetic polymorphism, i.e. a G-to-A substitution (GAG to GAA) at nucleotide position 13 432. Thus, the observed temperature sensitivity of OvBH-1 cells cannot be ascribed to a p53 primary structure mutation. Based upon immunochemical analyses, we consider, however, that p53 in nuclei of OvBH-1 cells is in a highly unstable conformation. Furthermore, the N-terminal portion of the p53 protein at Ser20 has not been modified, and Lys373 and / or Ser378 of the C-terminus is acetylated and / or phosphorylated. The nuclear location signal of p53 is preserved. Induction of MDM2 protein is uncoupled from the cell regulatory machinery and the induction of p21(WAF1) by p53 is impaired in OvBH-1 cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359050      PMCID: PMC5927136          DOI: 10.1111/j.1349-7006.2002.tb02473.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  63 in total

1.  p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

Authors:  A Ito; C H Lai; X Zhao; S Saito; M H Hamilton; E Appella; T P Yao
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

Review 2.  p53 and human cancer: the first ten thousand mutations.

Authors:  P Hainaut; M Hollstein
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

3.  Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs.

Authors:  B D Chang; Y Xuan; E V Broude; H Zhu; B Schott; J Fang; I B Roninson
Journal:  Oncogene       Date:  1999-08-26       Impact factor: 9.867

4.  Temperature-dependent switching between "wild-type" and "mutant" forms of p53-Val135.

Authors:  J Milner; E A Medcalf
Journal:  J Mol Biol       Date:  1990-12-05       Impact factor: 5.469

5.  Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.

Authors:  P L Judson; J M Watson; P A Gehrig; W C Fowler; J S Haskill
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

Review 6.  Functions of the MDM2 oncoprotein.

Authors:  D A Freedman; L Wu; A J Levine
Journal:  Cell Mol Life Sci       Date:  1999-01       Impact factor: 9.261

Review 7.  Clinical applications of detecting dysfunctional p53 tumor suppressor protein.

Authors:  I O Baas; R H Hruban; G J Offerhaus
Journal:  Histol Histopathol       Date:  1999-01       Impact factor: 2.303

8.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

9.  Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines.

Authors:  V Möbus; C D Gerharz; U Press; R Moll; T Beck; W Mellin; K Pollow; P G Knapstein; R Kreienberg
Journal:  Int J Cancer       Date:  1992-08-19       Impact factor: 7.396

10.  Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells.

Authors:  N Zaffaroni; R Silvestrini; L Orlandi; A Bearzatto; D Gornati; R Villa
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.